Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surrozen (SRZN) Common Equity (2021 - 2025)

Surrozen (SRZN) has 5 years of Common Equity data on record, last reported at -$23.5 million in Q3 2025.

  • For Q3 2025, Common Equity fell 514.95% year-over-year to -$23.5 million; the TTM value through Sep 2025 reached -$23.5 million, down 514.95%, while the annual FY2024 figure was -$21.4 million, 156.36% down from the prior year.
  • Common Equity reached -$23.5 million in Q3 2025 per SRZN's latest filing, down from $47.1 million in the prior quarter.
  • Across five years, Common Equity topped out at $123.7 million in Q3 2021 and bottomed at -$23.5 million in Q3 2025.
  • Average Common Equity over 5 years is $46.8 million, with a median of $45.5 million recorded in 2023.
  • The widest YoY moves for Common Equity: up 677.2% in 2025, down 514.95% in 2025.
  • A 5-year view of Common Equity shows it stood at $109.7 million in 2021, then tumbled by 30.72% to $76.0 million in 2022, then tumbled by 50.09% to $37.9 million in 2023, then tumbled by 156.36% to -$21.4 million in 2024, then decreased by 9.99% to -$23.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were -$23.5 million in Q3 2025, $47.1 million in Q2 2025, and $5.7 million in Q1 2025.